Cargando…

P1146: TRANSFUSION NEEDS AFTER CD19 CAR T-CELLS FOR LARGE B-CELL LYMPHOMA: PREDICTIVE FACTORS AND IMPACT ON OUTCOME. A DESCAR-T STUDY.

Detalles Bibliográficos
Autores principales:	Vic, Samuel, Thibert, Jean-Baptiste, Bachy, Emmanuel, Cartron, Guillaume, Gastinne, Thomas, Yakoub-Agha, Ibrahim, Le Bras, Fabien, Bouabdallah, Kamal, Despas, Fabien, Olivier Bay, Jacques, Rubio, Marie-Thérèse, Mohty, Mohamad, Olivier Casasnovas, Rene, Choquet, Sylvain, Castilla-Llorente, Cristina, Guidez, Stephanie, Loschi, Michael, Guffroy, Blandine, Carras, Sylvain, Rochelle, Laurianne Drieu La, Houot, Roch
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430941/ http://dx.doi.org/10.1097/01.HS9.0000971480.22232.d3

Ejemplares similares

Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry
por: Lemoine, Jean, et al.
Publicado: (2023)

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
por: Bachy, Emmanuel, et al.
Publicado: (2022)

Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma
por: Bouard, Louise, et al.
Publicado: (2022)

Cavity for 114.6 MHz
por: Croizat, M, et al.
Publicado: (1984)

S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY
por: Houot, Roch, et al.
Publicado: (2023)

Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
por: Houot, Roch, et al.
Publicado: (2023)

Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
por: Houot, Roch, et al.
Publicado: (2023)

P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION.
por: Le Gouill, Steven, et al.
Publicado: (2023)

Epidemiology of middle ear and mastoid cholesteatomas. Study of 1146 cases
por: de Aquino, Jose Evandro Andrade Prudente, et al.
Publicado: (2015)

1146. Effectiveness of Ultraviolet Irradiation on Candida auris: A Laboratory Study
por: Garmon, Gennifer, et al.
Publicado: (2018)

1146. Thrombocytosis in Infants with Congenital Cytomegalovirus Infection Being Treated with Valganciclovir
por: Murtagh, Kathleen, et al.
Publicado: (2020)

Carbon-Flux Distribution within Streptomyces coelicolor Metabolism: A Comparison between the Actinorhodin-Producing Strain M145 and Its Non-Producing Derivative M1146
por: Coze, Fabien, et al.
Publicado: (2013)

1146. Real-World Experience Highlighting Tocilizumab Use in the Treatment of COVID-19
por: Maguire, Christina, et al.
Publicado: (2022)

Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study
por: Bonnet, Antoine, et al.
Publicado: (2022)

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
por: Marouf, Amira, et al.
Publicado: (2023)

Genome Analysis of Environmental and Clinical P. aeruginosa Isolates from Sequence Type-1146
por: Sánchez, David, et al.
Publicado: (2014)

Total elbow replacement: outcome of 1,146 arthroplasties from the Scottish Arthroplasty Project
por: Jenkins, Paul J, et al.
Publicado: (2013)

1146. Lactococcus species Catheter-Related Bloodstream Infections in Pediatrics: A Case Series
por: Firmani, Sarah E, et al.
Publicado: (2021)

P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
por: Sarkozy, Clementine, et al.
Publicado: (2023)

1146 Prevalence of blood borne viruses in the dialysis unit, Mubarak Al-Kabeer Hospital, Kuwait
por: Altawalah, Haya, et al.
Publicado: (2014)

SG-APSIC1146: Reducing bacterial contamination in the dental unit waterline (DUWL) in dental clinics
por: Lang, Lily, et al.
Publicado: (2023)

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
por: Al Tabaa, Yassine, et al.
Publicado: (2023)

P1133: SUB-CUTANEOUS RITUXIMAB INDUCTION FOLLOWED BY SHORT RITUXIMAB MAINTENANCE IMPROVES PFS IN PATIENTS WITH LOW-TUMOR BURDEN FOLLICULAR LYMPHOMA. FINAL RESULTS OF FLIRT PHASE III TRIAL, A LYSA STUDY.
por: Cartron, G., et al.
Publicado: (2022)

1146. Antibiotic Use in Infants Predicts Asthma Rate in Children 1–4 years at Fine Geographic Scale
por: Mamun, Abdullah A, et al.
Publicado: (2019)

1146. Cost-effectiveness of the Pentavalent Meningococcal Vaccine (MenABCWY): A steady-state cohort modelling approach
por: Schley, Katharina, et al.
Publicado: (2023)

Dissection-enabled scaffold-assisted resection (DeSCAR): a novel technique for resection of residual or non-lifting gastrointestinal neoplasia of the colon, expanded experience and follow-up
por: Villa, Edward, et al.
Publicado: (2020)

Effects of leptin on sympathetic nerve activity in conscious mice
por: Morgan, Donald A, et al.
Publicado: (2015)

Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma
por: Le Gallou, Simon, et al.
Publicado: (2021)

Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies
por: Belliere, Julie, et al.
Publicado: (2021)

The pharmacology of blinatumomab: state of the art on pharmacodynamics, pharmacokinetics, adverse drug reactions and evaluation in clinical trials
por: Mocquot, Pauline, et al.
Publicado: (2022)

Cerebral localization of chronic myelomonocytic leukemia and improvement with high‐dose cytarabine: A case report
por: Haméon, Clémence, et al.
Publicado: (2023)

Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database
por: Tournaire, Guilhem, et al.
Publicado: (2020)

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
por: Houot, Roch, et al.
Publicado: (2020)

Sequence analysis of the 3′ end of the feline coronavirus FIPV 79-1146 genome: Comparison with the genome of porcine coronavirus TGEV reveals large insertions
por: De Groot, Raoul J., et al.
Publicado: (1988)

Two siblings suffering from Angelman Syndrome with a novel c.1146T>G mutation in UBE3A: A case report
por: Liu, Can, et al.
Publicado: (2022)

HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements
por: Mielcarek, Michal, et al.
Publicado: (2015)

Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
por: Bonnet, Christophe, et al.
Publicado: (2022)

Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab
por: Rodier, Cyrielle, et al.
Publicado: (2023)

Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey
por: Compaci, Gisèle, et al.
Publicado: (2019)

Electroretinography and contrast sensitivity, complementary translational biomarkers of sensory deficits in the visual system of individuals with fragile X syndrome
por: Perche, Olivier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_teaqkeuqs0ot17cf2sbjiv98ki